Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiko Tagawa

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Arzneimittel-Forschung|September 29, 2011
Investigation of the unique metabolic fate of ethyl (6R)-6- [N- (2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positionsFumihiro Jinno, Masaaki Kakehi, Toshiyuki Takeuchi, et al.
Basic & Clinical Pharmacology & Toxicology|January 19, 2018
Pre-clinical Characterization of Absorption, Distribution, Metabolism and Excretion Properties of TAK-063Kimio Tohyama, Miyako Sudo, Akio Morohashi, et al.
Clinical Calcium|November 29, 2012
[Space flight/bedrest immobilization and bone. Development a devise to maintain the skeletal muscles in space]Naoto Shiba, Hiroo Matsuse, Takeshi Nago, et al.
Biopharmaceutics & Drug Disposition|March 16, 2017
Influence of the pharmacokinetic profile on the plasma glucose lowering effect of the PPARγ agonist pioglitazone in Wistar fatty ratsAkihiko Goto, Yoshihiko Tagawa, Yoshiaki Kimura, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 26, 2018
Investigation of disposition for TAK-448, a synthetic peptide of kisspeptin analog, in rats and dogs using the radiolabeled TAK-448 suitable for pharmacokinetic studyYuu Moriya, Akifumi Kogame, Yoshihiko Tagawa, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Locomotion assistance for the person with mobility impairment: fuzzy control of cycling movement by means of surface electrical-stimulationYohei Ogawa, Takashi Inoue, Tomohisa Inada, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Basic study on a walking assist system with electrical stimulation for elderly peopleKazuhiro Funaki, Myu Shintani, Yoshio Takano, et al.
Journal of Rehabilitation Research and Development|August 13, 2013
Cycling exercise to resist electrically stimulated antagonist increases oxygen uptake in males: pilot studyHiroo Matsuse, Naoto Shiba, Yoshio Takano, et al.
European Journal of Pharmacology|March 28, 2018
Usefulness of pharmacokinetic/efficacy analysis of an investigational kisspeptin analog, TAK-448, in quantitatively evaluating anti-tumor growth effect in the rat VCaP androgen-sensitive prostate cancer modelKaori Ishikawa, Akira Tanaka, Akifumi Kogame, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2017
Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum AlbuminsNaohiro Narita, Akio Morohashi, Kimio Tohyama, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Arzneimittel-Forschung|September 29, 2011
Investigation of the unique metabolic fate of ethyl (6R)-6- [N- (2-chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positionsFumihiro Jinno, Masaaki Kakehi, Toshiyuki Takeuchi, et al.
Basic & Clinical Pharmacology & Toxicology|January 19, 2018
Pre-clinical Characterization of Absorption, Distribution, Metabolism and Excretion Properties of TAK-063Kimio Tohyama, Miyako Sudo, Akio Morohashi, et al.
Clinical Calcium|November 29, 2012
[Space flight/bedrest immobilization and bone. Development a devise to maintain the skeletal muscles in space]Naoto Shiba, Hiroo Matsuse, Takeshi Nago, et al.
Biopharmaceutics & Drug Disposition|March 16, 2017
Influence of the pharmacokinetic profile on the plasma glucose lowering effect of the PPARγ agonist pioglitazone in Wistar fatty ratsAkihiko Goto, Yoshihiko Tagawa, Yoshiaki Kimura, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 26, 2018
Investigation of disposition for TAK-448, a synthetic peptide of kisspeptin analog, in rats and dogs using the radiolabeled TAK-448 suitable for pharmacokinetic studyYuu Moriya, Akifumi Kogame, Yoshihiko Tagawa, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Locomotion assistance for the person with mobility impairment: fuzzy control of cycling movement by means of surface electrical-stimulationYohei Ogawa, Takashi Inoue, Tomohisa Inada, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Basic study on a walking assist system with electrical stimulation for elderly peopleKazuhiro Funaki, Myu Shintani, Yoshio Takano, et al.
Journal of Rehabilitation Research and Development|August 13, 2013
Cycling exercise to resist electrically stimulated antagonist increases oxygen uptake in males: pilot studyHiroo Matsuse, Naoto Shiba, Yoshio Takano, et al.
European Journal of Pharmacology|March 28, 2018
Usefulness of pharmacokinetic/efficacy analysis of an investigational kisspeptin analog, TAK-448, in quantitatively evaluating anti-tumor growth effect in the rat VCaP androgen-sensitive prostate cancer modelKaori Ishikawa, Akira Tanaka, Akifumi Kogame, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2017
Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum AlbuminsNaohiro Narita, Akio Morohashi, Kimio Tohyama, et al.
Pageof 6